CLINICAL TRIALS PROFILE FOR KHK7791
✉ Email this page to a colleague
Clinical Trials for KHK7791
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT03831607 ↗ | A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD | Completed | Kyowa Hakko Kirin Co., Ltd | Phase 2 | To evaluate the effect and safety of a switch from phosphate binders to KHK7791 to treat Hyperphosphatemia in patients on HD. |
NCT03831607 ↗ | A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD | Completed | Kyowa Kirin Co., Ltd. | Phase 2 | To evaluate the effect and safety of a switch from phosphate binders to KHK7791 to treat Hyperphosphatemia in patients on HD. |
NCT03864445 ↗ | Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients | Completed | Kyowa Hakko Kirin Co., Ltd | Phase 2 | To evaluate the effect and safety of KHK7791 in combination with phosphate binders to treat Hyperphosphatemia in ptatients on HD. |
NCT03864445 ↗ | Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients | Completed | Kyowa Kirin Co., Ltd. | Phase 2 | To evaluate the effect and safety of KHK7791 in combination with phosphate binders to treat Hyperphosphatemia in ptatients on HD. |
NCT03864458 ↗ | Dose-finding Study of KHK7791 in Hyperphosphatemia Patients | Completed | Kyowa Hakko Kirin Co., Ltd | Phase 2 | To evaluate the effect and safety of KHK7791 to treat Hyperphosphatemia in ptatients on HD. |
NCT03864458 ↗ | Dose-finding Study of KHK7791 in Hyperphosphatemia Patients | Completed | Kyowa Kirin Co., Ltd. | Phase 2 | To evaluate the effect and safety of KHK7791 to treat Hyperphosphatemia in ptatients on HD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for KHK7791
Condition Name
Clinical Trial Locations for KHK7791
Clinical Trial Progress for KHK7791
Clinical Trial Phase
Clinical Trial Sponsors for KHK7791
Sponsor Name